Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity
Protein disulfide isomerase (PDI) is a member of the thioredoxin superfamily of redox enzymes. PDI is a multifunctional protein that catalyzes disulfide bond formation, cleavage, and rearrangement in unfolded or misfolded proteins and functions as a chaperone in the endoplasmic reticulum. Besides ac...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Chemistry |
Online Access: | http://dx.doi.org/10.1155/2017/2370359 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832556780004048896 |
---|---|
author | Mariateresa Badolato Gabriele Carullo Francesca Aiello Antonio Garofalo |
author_facet | Mariateresa Badolato Gabriele Carullo Francesca Aiello Antonio Garofalo |
author_sort | Mariateresa Badolato |
collection | DOAJ |
description | Protein disulfide isomerase (PDI) is a member of the thioredoxin superfamily of redox enzymes. PDI is a multifunctional protein that catalyzes disulfide bond formation, cleavage, and rearrangement in unfolded or misfolded proteins and functions as a chaperone in the endoplasmic reticulum. Besides acting as a protein folding catalyst, several evidences have suggested that PDI can bind small molecules containing, for example, a phenolic structure, which includes the estrogenic one. Increasing studies indicate that PDI is involved in both physiology and pathophysiology of cells and tissues and is involved in the survival and proliferation of different cancers. Propionic acid carbamoyl methyl amides (PACMAs) showed anticancer activity in human ovarian cancer, both in vitro and in vivo, by inhibiting PDI. The inhibition of PDI’s activity may have a therapeutic role, in various diseases, including cancer. In the present study, we designed and synthesized a diversified small library of compounds with the aim of identifying a new class of PDI inhibitors. Most of synthesized compounds showed a good inhibitory potency against PDI and particularly 4-methyl substituted 2,6-di-tert-butylphenol derivatives (8–10) presented an antiproliferative activity in a wide panel of human cancer cell lines, including ovarian ones. |
format | Article |
id | doaj-art-e25db0996b4d4c1b869db907fc44d346 |
institution | Kabale University |
issn | 2090-9063 2090-9071 |
language | English |
publishDate | 2017-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Chemistry |
spelling | doaj-art-e25db0996b4d4c1b869db907fc44d3462025-02-03T05:44:29ZengWileyJournal of Chemistry2090-90632090-90712017-01-01201710.1155/2017/23703592370359Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative ActivityMariateresa Badolato0Gabriele Carullo1Francesca Aiello2Antonio Garofalo3Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, ItalyProtein disulfide isomerase (PDI) is a member of the thioredoxin superfamily of redox enzymes. PDI is a multifunctional protein that catalyzes disulfide bond formation, cleavage, and rearrangement in unfolded or misfolded proteins and functions as a chaperone in the endoplasmic reticulum. Besides acting as a protein folding catalyst, several evidences have suggested that PDI can bind small molecules containing, for example, a phenolic structure, which includes the estrogenic one. Increasing studies indicate that PDI is involved in both physiology and pathophysiology of cells and tissues and is involved in the survival and proliferation of different cancers. Propionic acid carbamoyl methyl amides (PACMAs) showed anticancer activity in human ovarian cancer, both in vitro and in vivo, by inhibiting PDI. The inhibition of PDI’s activity may have a therapeutic role, in various diseases, including cancer. In the present study, we designed and synthesized a diversified small library of compounds with the aim of identifying a new class of PDI inhibitors. Most of synthesized compounds showed a good inhibitory potency against PDI and particularly 4-methyl substituted 2,6-di-tert-butylphenol derivatives (8–10) presented an antiproliferative activity in a wide panel of human cancer cell lines, including ovarian ones.http://dx.doi.org/10.1155/2017/2370359 |
spellingShingle | Mariateresa Badolato Gabriele Carullo Francesca Aiello Antonio Garofalo Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity Journal of Chemistry |
title | Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity |
title_full | Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity |
title_fullStr | Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity |
title_full_unstemmed | Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity |
title_short | Synthesis and Experimental Validation of New PDI Inhibitors with Antiproliferative Activity |
title_sort | synthesis and experimental validation of new pdi inhibitors with antiproliferative activity |
url | http://dx.doi.org/10.1155/2017/2370359 |
work_keys_str_mv | AT mariateresabadolato synthesisandexperimentalvalidationofnewpdiinhibitorswithantiproliferativeactivity AT gabrielecarullo synthesisandexperimentalvalidationofnewpdiinhibitorswithantiproliferativeactivity AT francescaaiello synthesisandexperimentalvalidationofnewpdiinhibitorswithantiproliferativeactivity AT antoniogarofalo synthesisandexperimentalvalidationofnewpdiinhibitorswithantiproliferativeactivity |